Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 2,711

Tesla has removed Disney+ from some of its vehicles amid Elon Musk having an online fight with Disney CEO Bob Iger. The fight started when Disney halted its advertising on X after Musk agreed with and amplified antisemitic content, for which he eventually apologized.

Every week, there’s a new drama with Elon Musk on X, formerly known as Twitter. It sometimes indirectly affects Tesla, but this time, it affects it directly.

The current drama stems from Musk giving support to an antisemitic post on X, which he didn’t initially apologize for, though admitted that it was a mistake a week later. He further apologized but was already attacking Disney. In the meantime, the result was a massive backlash, where many companies stopped advertising on X, including Apple and Disney.

Read more | >

Intel’s Gaudi 3 AI accelerator reportedly employs the TSMC 5nm process and is expected to compete with NVIDIA H100 & AMD MI300X.

Intel Leverages TSMC’s 5nm Node For Gaudi 3 Accelerator, Launches Next Year To Compete Against NVIDIA H100 & AMD MI300X

Alongside the unveiling of Intel’s 5th-Gen Xeon Scalable and Core Ultra “Meteor Lake” CPUs, CEO Pat Gelsinger provided a small glimpse at the company’s next-gen AI accelerator, without giving out specifics about it. However, reports from the Korean media have revealed what Team Blue’s Gaudi 3 accelerator could bring on board, and it is expected to compete with NVIDIA’s H100 and AMD’s Instinct MI300X AI GPUs in terms of AI performance.

Read more | >

A new study in Nature reports an AI-driven advance in biotechnology with implications for drug development, disease detection, and environmental monitoring. Scientists at the Institute for Protein Design at the University of Washington School of Medicine used software to create protein molecules that bind with exceptionally high affinity and specificity to a variety of challenging biomarkers, including human hormones.

Notably, the scientists achieved the highest interaction strength ever reported between a computer-generated biomolecule and its target.

Senior author David Baker, professor of biochemistry at UW Medicine and Howard Hughes Medical Institute investigator, emphasized the potential impact: “The ability to generate novel proteins with such high binding affinity and specificity opens up a world of possibilities, from new disease treatments to advanced diagnostics.”

Read more | >

The threat actors associated with the 8220 Gang have been observed exploiting a high-severity flaw in Oracle WebLogic Server to propagate their malware.

The security shortcoming is CVE-2020–14883 (CVSS score: 7.2), a remote code execution bug that could be exploited by authenticated attackers to take over susceptible servers.

“This vulnerability allows remote authenticated attackers to execute code using a gadget chain and is commonly chained with CVE-2020–14882 (an authentication bypass vulnerability also affecting Oracle Weblogic Server) or the use of leaked, stolen, or weak credentials,” Imperva said in a report published last week.

Read more | >

Nearly two in five U.S. adults have high cholesterol, according to the Centers for Disease Control and Prevention (CDC). Untreated, high cholesterol can lead to heart disease and stroke, which are two of the top causes of death in the U.S. Worldwide; cardiovascular diseases claim nearly 18 million lives every year, according to the World Health Organization.

A new vaccine developed by researchers at The University of New Mexico School of Medicine could be a game-changer, providing an inexpensive method to lower “bad” LDL , which creates dangerous plaques that can block blood vessels.

In a recent study published in npj Vaccines, a team led by Bryce Chackerian, Ph.D., Regents’ Professor in the Department of Molecular Genetics & Microbiology, reported the vaccines lowered LDL cholesterol almost as effectively as an expensive class of drugs known as PCSK9 inhibitors.

Read more | >